Note: The start time of the fiscal year of each company is different from the natural year, so there may be inconsistencies between the fiscal quarter and the year and the natural year. Companies may report their results on a quarterly or semi-annual basis.
Johnson & Johnson (Johnson & Johnson) reports results for the second quarter of 2024. Quarterly sales were $22.447 billion, compared to $21.519 billion in the same period last year, a year-on-year increase of 4.3%. Quarterly net profit was US$4.686 billion, compared with US$5.376 billion in the same period last year, down 12.8% year-on-year. Adjusted net income was $6.84 billion, up 1.6% year-over-year. By business, sales of pharmaceutical business were US$14.49 billion, up 5.5% year-on-year. The sales of medical device business were 7.957 billion US dollars, a year-on-year increase of 2.2%.
Medtronic announced results for the fiscal first quarter ended July 26, 2024. Net sales for the quarter were $7,915 million, compared to $7,702 million in the year-ago quarter. Net income attributable to the Company for the quarter was $1,042 million, compared to $791 million in the year-ago quarter.
Abbott reports second-quarter 2024 results. Quarterly net sales were $10,377 million, compared to $9,978 million in the same period last year, an increase of 4% year-over-year. Net income for the quarter was $1,302 million, compared to $1,375 million in the year-ago quarter. By business, the revenue of the medical devices segment was $4.734 billion, an increase of 10.2% year-on-year. Nutrition revenue was $2.15 billion, up 3.5% year-over-year. Diagnostics revenue was $2.195 billion, down 5.3% year-on-year. Generic drug sales were $1.294 billion, up 0.6% year-on-year.
Siemens Healthineers announced results for the third quarter of fiscal 2024 ended June 30, 2024. Quarterly revenue was 5.423 billion euros (about 6.01 billion US dollars), compared with 5.201 billion euros in the same period last year, a year-on-year increase of 4.3%. Adjusted EBIT profit for the quarter was 825 million euros, compared to 758 million euros in the prior-year quarter. Net income for the quarter was 472 million euros, compared to 451 million euros in the prior-year quarter.
Danaher Inc. announces second-quarter 2024 results. Net sales for the quarter were $5,743 million, compared to $5,912 million in the year-ago quarter. Net income attributable to common shareholders for the quarter was $907 million, compared to $1,106 million for the year-ago quarter.
Stryker, a medical device and equipment manufacturer, announced results for the second quarter of 2024. Quarterly net sales were $5,422 million, compared to $4,996 million in the year-ago quarter, an increase of 8.5% year-over-year. Net income for the quarter was $825 million, compared to $738 million in the year-ago quarter, an increase of 11.8% year-over-year.
Fresenius Medical Care announces results for the second quarter of 2024. Quarterly revenue was 4,766 million euros (approximately $5,285 million), compared to 4,825 million euros in the prior-year period. Operating profit for the quarter was 425 million euros, compared to 357 million euros in the prior-year quarter. Net income for the quarter was 187 million euros, compared to 140 million euros in the prior-year quarter.
Netherlands healthcare company Koninklijke Philips N.V announced its results for the second quarter of 2024. Quarterly sales were 4,462 million euros (approximately $4,946 million), compared to 4,470 million euros in the prior-year quarter. Net income for the quarter was 452 million euros, compared to 74 million euros in the prior-year quarter. Adjusted EBITDA profit for the quarter was 733 million euros, compared to 681 million euros in the prior-year quarter.
BD announced results for the third quarter ended June 30, 2024. Quarterly revenue was $4.99 billion, compared to $4.878 billion in the year-ago quarter. Net income attributable to common shareholders for the quarter was $487 million, compared to $392 million in the year-ago quarter.
GE HealthCare reports second-quarter 2024 results. Total revenue for the quarter was $4,839 million, compared to $4,817 million in the year-ago quarter. Net income attributable to the Company for the quarter was $428 million, compared to $418 million in the year-ago quarter.
Thermo Fisher Scientific reports second-quarter 2024 results. Quarterly revenue was $10,541 million, compared to $10,687 million in the year-ago quarter. Net income attributable to the Company for the quarter was $1,548 million, compared to $1,361 million in the year-ago quarter. Among them, the revenue of life science business was US$2.355 billion, the revenue of laboratory products and biopharmaceutical services was US$5.758 billion, the revenue of professional diagnostics business was US$1.117 billion, and the revenue of analytical instruments was US$1.783 billion.
Roche announces results for the first half of 2024. Group sales amounted to 29,848 million Switzerland francs, compared to 29,779 million Switzerland francs in the prior-year period. Operating profit for the period was 11,293 million Switzerland francs, compared to 10,911 million Switzerland francs in the prior-year quarter. Net profit for the period was 6,697 million Switzerland francs, compared to 7,563 million Switzerland francs in the prior-year period. Sales in the pharmaceutical business amounted to Switzerland 22,637 million francs, compared to 22,511 million Switzerland francs in the prior-year period. Diagnostics sales amounted to 7,211 million Switzerland francs (approximately $8.5 billion), compared to 7,268 million Switzerland francs in the prior-year quarter.
Boston Scientific reports second-quarter 2024 results. Net sales for the quarter were $4,120 million. This represents an increase of 14.5% compared to the same period last year. Net income for common shareholders was $324 million, compared to $261 million in the year-ago quarter.
Baxter International Inc Announces Second Quarter 2024 Results. Net sales for the quarter were $3,812 million, compared to $3,707 million in the year-ago quarter. Net loss attributable to shareholders of the Company for the quarter was $314 million, compared to a net loss of $141 million in the year-ago quarter.
Henry Schein announces results for the second quarter of 2024. Net sales for the quarter were $3,136 million, compared to $3.1 billion in the year-ago quarter. Net income attributable to the Company for the quarter was $104 million, compared to $140 million in the year-ago quarter.
Cardinal Health announced its results for the fourth fiscal quarter and fiscal year ended June 30, 2024. Revenue for the fourth quarter was $59.867 billion, and net profit attributable to the company was $235 million. The revenue for the fiscal year was 226.827 billion US dollars, and the net profit attributable to the company was 852 million US dollars. Among them, the medical products and distribution business generated revenue of $3.1 billion and profit of $47 million in the fourth quarter. Revenue for the fiscal year was $12.4 billion and profit was $92 million.
Owens & Minor announces results for the second quarter of 2024. Net revenue for the quarter was $2,671 million, compared to $2,563 million in the year-ago quarter. Net loss for the quarter was $31.91 million, compared to a net loss of $28.24 million in the year-ago quarter.
Solventum (formerly 3M Healthcare) announced results for the second quarter of 2024. Total net sales for the quarter were $2,081 million, compared to $2,076 million in the year-ago quarter. Net income for the quarter was $89 million, compared to $321 million in the year-ago quarter.
Intuitive Surgical, Inc. Announced results for the second quarter of 2024. Total revenue for the quarter was $2.01 billion, compared to $1.756 billion in the year-ago quarter. Net income attributable to the Company for the quarter was $527 million, compared to $421 million in the year-ago quarter. Devices and accessories revenue for the period increased 16% year-over-year to $1.24 billion. The number of da Vinci surgical systems installed reached 9,203, a year-on-year increase of 14%.
Zimmer Biomet Holdings Inc. announced results for the second quarter of 2024. Net sales for the quarter were $1,942 million, compared to $1,870 million in the year-ago quarter. Net income attributable to the Company for the quarter was $243 million, compared to $210 million in the year-ago quarter.
Terumo announced results for the fiscal first quarter ended June 30, 2024. Quarterly revenue was 258.194 billion yen (about 1.776 billion US dollars), compared with 215.252 billion yen in the same period last year, a year-on-year increase of 19.9%. Operating profit for the quarter was 44.64 billion yen, compared to 29.644 billion yen in the same period of the previous year, a year-on-year increase of 50.6%. Net profit attributable to owners of the parent company for the quarter was 33,891 million yen, compared to 22,549 million yen in the same period of the previous year, a year-on-year increase of 50.3%.
OLYMPUS ANNOUNCED RESULTS FOR THE FISCAL FIRST QUARTER ENDED JUNE 30, 2024. Quarterly revenue was 234.821 billion yen (about 1.616 billion US dollars), compared with 204.985 billion yen in the same period last year, a year-on-year increase of 14.6%. Operating profit for the quarter was 27.477 billion yen, compared to 22.626 billion yen in the same period of the previous year, a year-on-year increase of 21.4%. Net profit attributable to owners of the parent company for the quarter was 14.583 billion yen, compared to 240.56 billion yen in the same period of the previous year, a year-on-year decrease of 93.9%.
Fujifilm Holdings announced its results for the first quarter of the fiscal year ended June 30, 2024. Group sales increased by 13.4% year-on-year to 749 billion yen. Operating profit increased by 19.1% year-on-year to 62.2 billion yen, driven by overall sales growth and currency effects, and net income attributable to the Group increased by 11.6% year-on-year to 60.7 billion yen. By business segment, revenue from the healthcare business increased by 10.8% year-on-year to 229.2 billion yen (approximately USD 1.58 billion). Revenue from the electronic materials business increased by 37.9% year-on-year to 109.1 billion yen. Revenue from the imaging business increased by 24.2% year-on-year to 105.2 billion yen. Business innovation revenue increased by 3.9% year-on-year to 280 billion yen.
Mindray Medical released its 2024 semi-annual report. During the reporting period, the company achieved operating income of 20.531 billion yuan (about 2.89 billion US dollars), a year-on-year increase of 11.12%; net profit attributable to shareholders of listed companies was 7.561 billion yuan, a year-on-year increase of 17.37%.
Canon Group (Canon) released its financial results for the second quarter of 2024. Group turnover in the second quarter increased by 14.4% year-on-year to 1,167.786 billion yen. Operating profit increased by 28.3% year-on-year to 118.391 billion yen. Net profit increased by 37.4% year-on-year to 89.857 billion yen. Among them, the turnover of the printing business increased by 13.8% year-on-year to 654.5 billion yen. Revenue in the medical business area increased by 11.8% year-on-year to 141 billion yen (approximately 970 million US dollars). Revenue in the imaging business increased by 11.6% year-on-year to 244.7 billion yen. Turnover in the industrial segment increased by 26.2% year-on-year to 94.5 billion yen.
ophthalmology
Essilor Luxottica announces its results for the first half of 2024. Revenue for the period was 13.29 billion euros, compared to 12.851 billion euros in the prior-year quarter. Operating profit was 1,943 million euros, compared to 1,832 million euros in the prior-year quarter. Net profit attributable to owners of the parent company amounted to 1,365 million euros, compared to 1,361 million euros in the prior-year quarter. Among them, professional solutions revenue was 6.414 billion euros (about 7.11 billion US dollars), compared with 6.234 billion euros in the same period of the previous year. Revenues in the consumer business were 6,876 million euros, compared to 6,616 million euros in the prior-year quarter.
Alcon reports results for the second quarter of 2024. Net sales for the quarter were $2,482 million, compared to $2,402 million in the year-ago quarter. Net income for the quarter was $223 million, compared to $169 million in the year-ago quarter.
Bausch+Lomb reports results for the second quarter of 2024. Quarterly revenue was $1,216 million, compared to $1,035 million in the year-ago quarter. Net loss attributable to the Company for the quarter was $151 million, compared to a net loss of $32 million in the year-ago quarter.
Recommend a global pharmaceutical industry information account